trending Market Intelligence /marketintelligence/en/news-insights/trending/eur3ra-28tgaj8lq0un2jw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

BioTime sells minority stake in JV

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

BioTime sells minority stake in JV

Alameda, Calif.-based BioTime Inc. sold its minority stake in privately held Ascendance Biotechnology Inc. for $3.5 million.

IVT Holdings acquired Ascendance and has already paid $3.2 million to AgeX Therapeutics Inc., a subsidiary of BioTime. The remaining $300,000 will be paid later.

"This cash will help fund AgeX programs and operational expenses, as it continues to grow and establish an even larger presence in the field of aging and age-related diseases," BioTime co-CEO Aditya Mohanty said in a statement.

Ascendance was created in late 2015 as a joint venture between BioTime and Hepregen Corp. to offer a broad portfolio of assays and research products and services.